Solace Health
Solace provides professional health advocates who help patients navigate care by handling scheduling, paperwork, and communication with medical teams.
Secondary Market Price
Secondary Market Price
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Solace Health's value.
Sign up to Unlock the Latest DataProspect Projected Future Solace Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Solace Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Solace operates as a healthcare advocacy and navigation company that connects patients with health advocates—a team of doctors, nurses, and healthcare administrators. These advocates assist users in managing the complexities of the U.S. healthcare system, from handling paperwork and scheduling appointments to communicating with medical teams and understanding insurance plans. The company partners with payers, such as insurance companies, to offer its services to their members, and its services are fully reimbursed by Medicare. Founded in 2022, the private, venture-backed company is headquartered in Austin, Texas, and has raised capital through multiple funding rounds since its inception.
Looking forward, Solace's recent activities suggest a period of significant growth. The company completed a Series B funding round on April 3, 2025, raising $60 million, which brought its total funding to $81 million. This capital infusion was supported by investors including Optum Ventures, SignalFire, and Craft Ventures. In addition to the new funding, the company is actively hiring for numerous positions across its engineering, product management, clinical quality, and analytics departments. These developments point toward plans to scale operations and expand its service offerings in the near future.
- Menlo Ventures
- Craft
- SignalFire
- Inspired Capital
- RiverPark Ventures
- Anne Wojcicki
- Susan Wojcicki
- Co-Founder, CEO Jeremy Gurewitz
- Co-Founder, Sara Sargent
Peer Group Comparison
Vs Peer Group of >$4B Startups
How Solace Health Measures Up
To help you manage your Solace Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We're still gathering data to complete our evaluation of Solace Health. Check back soon for our rating and our projection of the company's worth four years from now.
Exit Risk
TBD
We are still gathering data on Solace Health to train our machine learning model. Check back soon for our exit risk rating for Solace Health!
Funding Stage
Series B
For a potential employee, Solace Health's Series B status indicates it has moved beyond the initial startup risks and is now focused on scaling its operations. This often means you're joining a more stable environment that still offers significant opportunities to shape the company's future as it expands.
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Solace Health worth joining?
Determining if a private company is worth joining requires evaluating its growth potential and the likely value of its equity compensation. Platforms like Prospect use data and models similar to those of venture capitalists to help you assess a startup's future prospects.
What should I do with my Solace Health stock?
Managing your startup stock involves creating a strategy for exercising options and selling shares to maximize your financial outcome. Prospect provides tools to help you manage your equity by modeling tax implications and optimizing your decisions.
Can you sell Solace Health stock?
As Solace Health is a private company, its stock is not available on public exchanges, but selling is often possible on secondary markets. Prospect can provide insights into secondary market pricing and help you develop a tax-optimized selling strategy.
How can I find the value of my Solace Health stock?
The value of private stock is typically estimated using the company's latest 409A valuation, recent funding rounds, and secondary market sales data. You can use Prospect’s platform to get an independent projection of what your equity is likely to be worth.
What is Solace Health's equity worth?
A private company's total equity value is based on its most recent valuation, which is set during funding rounds. To understand the potential value of your personal stake, you can use tools from Prospect that project your equity's worth based on various growth scenarios.
What is Solace Health's stock ticker symbol?
Solace Health does not have a stock ticker symbol because it is a private company whose shares are not traded on a public stock exchange. A ticker symbol is only assigned after a company completes an Initial Public Offering (IPO).
Can I buy or sell Solace Health stock?
Employees can typically "buy" stock by exercising their options, while selling is often possible through secondary market transactions before an IPO. Prospect offers tools to help you create tax-efficient strategies for both exercising and selling your shares.
What is the criteria to buy or invest in Solace Health stock?
For employees, the main criterion is being granted stock options, while direct investment is usually reserved for accredited investors in private placements. You can evaluate the investment's quality by using Prospect's data on metrics like investor quality, company growth, and founder background.
